Current clinical management of dysfunctional bioprosthetic pulmonary valves.
Varun AggarwalZachary A SpigelGurumurthy HiremathZiyad BinsalamahAthar M QureshiPublished in: Expert review of cardiovascular therapy (2020)
Introduction: As with any bioprosthetic valve, bioprosthetic valves in the pulmonary position have a finite life span and patients with bioprosthetic pulmonary valves require lifetime management to treat valve dysfunction.Areas covered: In this article, authors discuss the current medical management for the treatment of dysfunctional bioprosthetic valves. This review is based on both an extensive review of the recent cardiac surgical/interventional cardiology literature (PubMed and MEDLINE database searches from 1958 to 2019) and personal experience.Expert opinion: Valve technology is rapidly progressing and with a coordinated effort from cardiac surgeons and interventional cardiologists, patients suffering from bioprosthetic pulmonary valve dysfunction can expect to have a decreased number of procedures and less invasive procedures over their lifetime now.
Keyphrases
- aortic valve
- aortic valve replacement
- aortic stenosis
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- pulmonary hypertension
- ejection fraction
- mitral valve
- end stage renal disease
- left ventricular
- oxidative stress
- healthcare
- chronic kidney disease
- newly diagnosed
- systematic review
- peritoneal dialysis
- heart failure
- cardiac surgery
- emergency department
- prognostic factors
- clinical practice